Medtronic Receives CE Mark for CoreValve System
May 23, 2013 at 06:00 AM EDT
Medtronic, Inc. (NYSE: MDT ) today announced it has received Conformité Européenne (CE) Mark for valve-in-valve (VIV) procedures using the CoreValve® and CoreValve® Evolut(TM) transcatheter aortic valve implantation (TAVI) systems in degenerated bioprosthetic surgical aortic valves. This is the first ever regulatory approval for VIV procedures, which provide a